c-Src-dependent cross-talk between CEACAM6 and αvβb integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components

被引:37
作者
Duxbury, MS [1 ]
Ito, H [1 ]
Ashley, SW [1 ]
Whang, EE [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
关键词
pancreatic; adenocarcinoma; canccr; CEACAM6; integrin fibronectin; vitronectin; Src; metastasis;
D O I
10.1016/j.bbrc.2004.03.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an immunoglobulin supcrfamily member with a diversity of extracellular ligands that is implicated in the initiation and progression of a variety of malignancies. We sought to characterize the effects of CEACAM6 crosslinking on pancreatic adenocarcinoma cellular interaction with the extracellular matrix (ECM) components fibronectin and vitronectin. Antibody-mediated CEACAM6 crosslinking was performed and the ability of BxPC3 cells, which inherently overexpress CEACAM6, to adhere to fibronectin and vitronectin was quantified. The roles of the archetypal fibronectin (alpha(5)beta(1) integrin) and vitronectin (alpha(v)beta(3) integrin) receptors were determined. The effects of c-Src inhibition were investigated using the Src family kinase inhibitor-4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) and c-Src specific RNA interference. CEACAM6 crosslinking initiates c-Si-c-dependent cross-talk between CEACAM6 and of beta-integrin, leading to increased ECM component adhesion. CEACAM6-mediated signaling events may contribute to the invasive and metastatic potential of pancreatic adenocarcinoma cells by promoting their interaction with ECM components. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 52 条
[21]   INTEGRINS - VERSATILITY, MODULATION, AND SIGNALING IN CELL-ADHESION [J].
HYNES, RO .
CELL, 1992, 69 (01) :11-25
[22]   Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation [J].
Ilantzis, C ;
Demarte, L ;
Screaton, RA ;
Stanners, CP .
NEOPLASIA, 2002, 4 (02) :151-163
[23]   Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness [J].
Ito, H ;
Gardner-Thorpe, J ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
SURGERY, 2003, 134 (02) :221-226
[24]   Elevated c-Src is linked to altered cell-matrix adhesion rather than proliferation in KM1 2C human colorectal cancer cells [J].
Jones, RJ ;
Avizienyte, E ;
Wyke, AW ;
Owens, DW ;
Brunton, VG ;
Frame, MC .
BRITISH JOURNAL OF CANCER, 2002, 87 (10) :1128-1135
[25]   C-SRC ENHANCES THE SPREADING OF SRC-/-FIBROBLASTS ON FIBRONECTIN BY A KINASE-INDEPENDENT MECHANISM [J].
KAPLAN, KB ;
SWEDLOW, JR ;
MORGAN, DO ;
VARMUS, HE .
GENES & DEVELOPMENT, 1995, 9 (12) :1505-1517
[26]   Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts [J].
Kasahara, K ;
Watanabe, K ;
Takeuchi, K ;
Kaneko, H ;
Oohira, A ;
Yamamoto, T ;
Sanai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34701-34709
[27]  
Kerr JS, 1999, ANTICANCER RES, V19, P959
[28]   MANNOSAMINE, A NOVEL INHIBITOR OF GLYCOSYL-PHOSPHATIDYLINOSITOL INCORPORATION INTO PROTEINS [J].
LISANTI, MP ;
FIELD, MC ;
CARAS, IW ;
MENON, AK ;
RODRIGUEZBOULAN, E .
EMBO JOURNAL, 1991, 10 (08) :1969-1977
[29]   ACTIVATION OF HUMAN MONOCYTES AND GRANULOCYTES BY MONOCLONAL-ANTIBODIES TO GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED ANTIGENS [J].
LUNDJOHANSEN, F ;
OLWEUS, J ;
SYMINGTON, FW ;
ARLI, A ;
THOMPSON, JS ;
VILELLA, R ;
SKUBITZ, K ;
HOREJSI, V .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (11) :2782-2791
[30]   Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma [J].
Lutz, MP ;
Esser, IBS ;
Flossmann-Kast, BBM ;
Vogelmann, R ;
Lührs, H ;
Friess, H ;
Büchler, MW ;
Adler, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (02) :503-508